148 related articles for article (PubMed ID: 19562874)
1. [Rehabilitation in haemophilic children with inhibitors using recombinant activated factor VII].
Janić D; Petronić I; Dokmanović L; Krstovski N; Lazić J; Rodić P
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():226-30. PubMed ID: 19562874
[TBL] [Abstract][Full Text] [Related]
2. [Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor].
Antić D; Elezović I; Sufajdzić N; Todorović M; Bila J; Mitrović M; Andjelkovic N
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():218-21. PubMed ID: 19562872
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
Obergfell A; Auvinen MK; Mathew P
Haemophilia; 2008 Mar; 14(2):233-41. PubMed ID: 18081827
[TBL] [Abstract][Full Text] [Related]
4. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
Takedani H; Kawahara H; Kajiwara M
Haemophilia; 2010 Mar; 16(2):290-5. PubMed ID: 19925628
[TBL] [Abstract][Full Text] [Related]
5. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
[TBL] [Abstract][Full Text] [Related]
6. Some recent developments regarding arthropathy and inhibitors in haemophilia.
Rodriguez-Merchan EC
Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
[TBL] [Abstract][Full Text] [Related]
7. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J
Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
[TBL] [Abstract][Full Text] [Related]
8. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
9. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors.
Santagostino E; Escobar M; Ozelo M; Solimeno L; Arkhammar P; Lee HY; Rosu G; Giangrande P
Blood Rev; 2015 Jun; 29 Suppl 1():S9-18. PubMed ID: 26073369
[TBL] [Abstract][Full Text] [Related]
11. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.
Habermann B; Hochmuth K; Hovy L; Scharrer I; Kurth AH
Haemophilia; 2004 Nov; 10(6):705-12. PubMed ID: 15569165
[TBL] [Abstract][Full Text] [Related]
12. The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.
Castaman G
Blood Transfus; 2017 Sep; 15(5):478-486. PubMed ID: 28686157
[TBL] [Abstract][Full Text] [Related]
13. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
[No Abstract] [Full Text] [Related]
14. Prevention of haemophilic arthropathy in haemophilic children with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2008 Nov; 14 Suppl 6():1-3. PubMed ID: 19134025
[TBL] [Abstract][Full Text] [Related]
15. Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.
Saxon BR; Shanks D; Jory CB; Williams V
Thromb Haemost; 2001 Oct; 86(4):1126-7. PubMed ID: 11686341
[No Abstract] [Full Text] [Related]
16. Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
Rodriguez-Merchan EC; Hedner U; Heijnen L; Jimenez-Yuste V; Lee CA; Morfini M; Querol F; Roosendaal G; Santagostino E; Solimeno LP
Haemophilia; 2008 Nov; 14 Suppl 6():68-81. PubMed ID: 19134036
[TBL] [Abstract][Full Text] [Related]
17. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
Young G; Shafer FE; Rojas P; Seremetis S
Haemophilia; 2008 Mar; 14(2):287-94. PubMed ID: 18081834
[TBL] [Abstract][Full Text] [Related]
18. Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I; Rodriguez-Merchan EC
Haemophilia; 2002 May; 8(3):288-91. PubMed ID: 12010425
[TBL] [Abstract][Full Text] [Related]
19. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Valentino LA; Cooper DL; Goldstein B
Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
[TBL] [Abstract][Full Text] [Related]
20. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.
Kavakli K; Makris M; Zulfikar B; Erhardtsen E; Abrams ZS; Kenet G;
Thromb Haemost; 2006 Apr; 95(4):600-5. PubMed ID: 16601828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
